Cigna Group
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FS-7
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
| (In millions) | Balance at beginning of year | Charged (Credited) to costs and expenses | Charged (Credited) to other accounts | Other deductions | Balance at end of year |
|---|---|---|---|---|---|
| Description | |||||
| Investment asset valuation reserves | |||||
| Available-for-sale debt securities | $44 | $11 | $— | $(22) | $33 |
| Commercial mortgage loans | $21 | $10 | $— | $— | $31 |
| Accounts receivable, net | $160 | $90 | $1 | $(88) | $163 |
| Deferred tax asset valuation allowance | $208 | $1,286 | $4 | $— | $1,498 |
| Reinsurance recoverables | $35 | $— | $— | $— | $35 |
| Investment asset valuation reserves | |||||
| Available-for-sale debt securities | $23 | $43 | $— | $(22) | $44 |
| Commercial mortgage loans | $6 | $15 | $— | $— | $21 |
| Accounts receivable, net | $126 | $99 | $— | $(65) | $160 |
| Deferred tax asset valuation allowance | $246 | $(13) | $(25) | $— | $208 |
| Reinsurance recoverables (1) | $28 | $7 | $— | $— | $35 |
| Investment asset valuation reserves | |||||
| Available-for-sale debt securities | $26 | $29 | $— | $(32) | $23 |
| Commercial mortgage loans | $6 | $— | $— | $— | $6 |
| Accounts receivable, net | $156 | $54 | $— | $(84) | $126 |
| Deferred tax asset valuation allowance | $207 | $23 | $16 | $— | $246 |
| Reinsurance recoverables (1) | $30 | $(2) | $— | $— | $28 |
(1)Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts ("LDTI") in 2023. See Note 2 to the Consolidated Financial Statements included in Part II, Item 8 of this Form 10-K for further information.
FS-7
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.